Jennifer A. Chan

Target (United States) — United States

Medicine · Health Sciences

78h-index27.5kcitations391works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(105), Cancer Genomics and Diagnostics(37), MicroRNA in disease regulation(27), Neuroblastoma Research and Treatments(27), Chromatin Remodeling and Cancer(26)

Publications388 total

EXTH-103. A prototype mRNA LNP neoantigen vaccine remodels the tumour microenvironment of a syngeneic model of glioblastoma
Neuro-Oncology·2025Open Access
EXTH-64. Allogeneic CAR-DNT cell therapy to overcome spatial heterogeneity in glioblastoma
Neuro-Oncology·2025Open Access
TMOD-40. Genetic drivers shape tumor phenotype and composition of the tumor microenvironment in syngeneic mouse models of glioblastoma
Neuro-Oncology·2025Open Access
IMMU-54. Leveraging deep immunopeptidomics to identify tumor antigens from glioblastoma tissue samples
Neuro-Oncology·2025
TMIC-120. Investigating EGFRvIII mRNA LNP vaccine-induced re-programming of the GBM TME using the 10x Genomics Visium HD platform
Neuro-Oncology·2025Open Access
DNAR-11. Differential DNA Damage and Repair burden in proliferating neural progenitor cells
Neuro-Oncology·2025Open Access
IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms
Neuro-Oncology Advances·2025Open Access
Screen Time and Standardized Academic Achievement Tests in Elementary School
JAMA Network Open·2025· 2 citedOpen Access
1712P Efficacy and safety of cabozantinib (CABO) for advanced lung and thymic neuroendocrine tumors (NET) after progression on prior therapy: Subgroup analysis of phase III CABINET Trial (Alliance A021602)
Annals of Oncology·2025
36 ISOLATION OF CANDIDATE GLIOBLASTOMA-INITIATING CELLS FROM MULTIPLE REGIONS OF THE ADULT MAMMALIAN BRAIN USING PLATELET-DERIVED GROWTH FACTOR C
Neuro-Oncology Advances·2025Open Access
Identification of a Second‐Hit Brain Somatic <scp> <i>DEPDC5</i> </scp> Variant Supports Causality of a <scp> <i>DEPDC5</i> </scp> Germline Variant of Uncertain Significance. Time for a Classification Update?
American Journal of Medical Genetics Part A·2025Open Access
Figure S1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
Figure 5 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Figshare·2025Open Access
Table S2 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
Figure S4 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Figshare·2025Open Access
Data from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
Figure S2 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Figshare·2025Open Access
Figure S3 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Figshare·2025Open Access
Figure 4 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
Table S1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
page 1 of 20Next →

Frequent Co-authors

Nada Jabado(12), Michael D. Taylor(12), Péter Hauser(11), Cynthia Hawkins(11), Marc Remke(10), Éric Bouffet(10), Vijay Ramaswamy(10), Betty Luu(9), Seung‐Ki Kim(9), Wiesława Grajkowska(9), Ho‐Keung Ng(9), Charles G. Eberhart(9), Álmos Klekner(9), Cláudia C. Faria(9), Annie Huang(9), Peter B. Dirks(9), Livia Garzia(8), A. Sorana Morrissy(8), Uri Tabori(8), Charles S. Fuchs(8)